GINA Implementation Improves Asthma Symptoms Control and Lung Function: A Five-Year Real-World Follow-Up Study

Area of Science:

• Pulmonology
• Clinical Medicine
• Respiratory Health

Background:

• Asthma symptom control remains a significant challenge for many patients.
• The Global Initiative for Asthma (GINA) provides evidence-based guidelines for asthma management.
• Long-term effectiveness of GINA implementation on asthma control and lung function requires evaluation.

Purpose of the Study:

• To assess asthma symptom control and lung function over five years following GINA guideline implementation.
• To evaluate the sustained impact of GINA recommendations on patient outcomes.
• To analyze changes in asthma control levels and airflow limitation.

Main Methods:

• A longitudinal study including 1388 asthma patients managed per GINA recommendations.
• Data collected from the Asthma and COPD Outpatient Care Unit (ACOCU) in Ho Chi Minh City, Vietnam.
• Assessment of asthma control and lung function over a 10-year period (October 2006 - October 2016).

Main Results:

• The proportion of patients with well-controlled asthma increased significantly from 2.6% at baseline to over 57% throughout the 5-year follow-up (p < 0.0001).
• Persistent airflow limitation decreased significantly from 26.7% at baseline to approximately 12-15% during the follow-up years (p < 0.0011).
• Improvements in asthma symptom control and lung function were observed within 3 months and sustained for 5 years.

Conclusions:

• Management of asthma according to GINA recommendations leads to significant and sustained improvements in symptom control.
• GINA guidelines effectively enhance lung function and reduce persistent airflow limitation in asthma patients.
• The study highlights the long-term benefits of adhering to GINA guidelines for comprehensive asthma care.